| Dr Pamela Gutbier Meliski, MD | |
|
75b Livingston St, Asheville, NC 28801-4353 | |
| (828) 258-8800 | |
| Not Available |
| Full Name | Dr Pamela Gutbier Meliski |
|---|---|
| Gender | Female |
| Speciality | Orthopedic Surgery |
| Experience | 21 Years |
| Location | 75b Livingston St, Asheville, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063694784 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0004X | Orthopaedic Surgery - Foot And Ankle Surgery | 2009-01543 (North Carolina) | Secondary |
| 207X00000X | Orthopaedic Surgery | 118025 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Mission Hospital And Asheville Surgery Ce | Asheville, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mh Angel Medical Center, Lllp | 8022359512 | 12 |
| Mission Health Community Multispecialty Providers Llc | 9537468574 | 577 |
News Archive
AMRI announced today that on-going results from its Phase I clinical study on its novel tubulin inhibitor, ALB 109564(a), were published on the website of the American Society of Clinical Oncology (abstract.asco.org/alb). These results indicate that ALB 109564(a) is well tolerated at the doses tested and shows preliminary evidence of clinical activity in disease types not typically treated with approved vinca alkaloids.
In 2010, the total cost of cancer care in the United States reached $125 billion. Globally, the economic toll from cancer is nearly 20 percent higher than the leading cause of death, heart disease. Cancer patients are also living longer today, which is further increasing the cost of their continued care.
Imagine creating an eye chart for someone who can't read or tell you what they see.
The National Institutes of Health is trying to cope with the effects of the government shutdown on patients and medical research.
The landmark breast cancer screening study of women 40-49, published online in Cancer, has proven that annual mammography screening of women in their 40s reduces the breast cancer death rate in these women by nearly 30 percent.
› Verified 7 days ago
| Entity Name | Blue Ridge Bone & Joint Clinic, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457308827 PECOS PAC ID: 9234114703 Enrollment ID: O20040619000047 |
News Archive
AMRI announced today that on-going results from its Phase I clinical study on its novel tubulin inhibitor, ALB 109564(a), were published on the website of the American Society of Clinical Oncology (abstract.asco.org/alb). These results indicate that ALB 109564(a) is well tolerated at the doses tested and shows preliminary evidence of clinical activity in disease types not typically treated with approved vinca alkaloids.
In 2010, the total cost of cancer care in the United States reached $125 billion. Globally, the economic toll from cancer is nearly 20 percent higher than the leading cause of death, heart disease. Cancer patients are also living longer today, which is further increasing the cost of their continued care.
Imagine creating an eye chart for someone who can't read or tell you what they see.
The National Institutes of Health is trying to cope with the effects of the government shutdown on patients and medical research.
The landmark breast cancer screening study of women 40-49, published online in Cancer, has proven that annual mammography screening of women in their 40s reduces the breast cancer death rate in these women by nearly 30 percent.
› Verified 7 days ago
| Entity Name | Mission Health Community Multispecialty Providers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457719130 PECOS PAC ID: 9537468574 Enrollment ID: O20160426001883 |
News Archive
AMRI announced today that on-going results from its Phase I clinical study on its novel tubulin inhibitor, ALB 109564(a), were published on the website of the American Society of Clinical Oncology (abstract.asco.org/alb). These results indicate that ALB 109564(a) is well tolerated at the doses tested and shows preliminary evidence of clinical activity in disease types not typically treated with approved vinca alkaloids.
In 2010, the total cost of cancer care in the United States reached $125 billion. Globally, the economic toll from cancer is nearly 20 percent higher than the leading cause of death, heart disease. Cancer patients are also living longer today, which is further increasing the cost of their continued care.
Imagine creating an eye chart for someone who can't read or tell you what they see.
The National Institutes of Health is trying to cope with the effects of the government shutdown on patients and medical research.
The landmark breast cancer screening study of women 40-49, published online in Cancer, has proven that annual mammography screening of women in their 40s reduces the breast cancer death rate in these women by nearly 30 percent.
› Verified 7 days ago
| Entity Name | Mh Angel Medical Center, Lllp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093284010 PECOS PAC ID: 8022359512 Enrollment ID: O20191114002579 |
News Archive
AMRI announced today that on-going results from its Phase I clinical study on its novel tubulin inhibitor, ALB 109564(a), were published on the website of the American Society of Clinical Oncology (abstract.asco.org/alb). These results indicate that ALB 109564(a) is well tolerated at the doses tested and shows preliminary evidence of clinical activity in disease types not typically treated with approved vinca alkaloids.
In 2010, the total cost of cancer care in the United States reached $125 billion. Globally, the economic toll from cancer is nearly 20 percent higher than the leading cause of death, heart disease. Cancer patients are also living longer today, which is further increasing the cost of their continued care.
Imagine creating an eye chart for someone who can't read or tell you what they see.
The National Institutes of Health is trying to cope with the effects of the government shutdown on patients and medical research.
The landmark breast cancer screening study of women 40-49, published online in Cancer, has proven that annual mammography screening of women in their 40s reduces the breast cancer death rate in these women by nearly 30 percent.
› Verified 7 days ago
| Entity Name | Mh Mission Hospital Mcdowell, Lllp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225513948 PECOS PAC ID: 0345581856 Enrollment ID: O20191119001720 |
News Archive
AMRI announced today that on-going results from its Phase I clinical study on its novel tubulin inhibitor, ALB 109564(a), were published on the website of the American Society of Clinical Oncology (abstract.asco.org/alb). These results indicate that ALB 109564(a) is well tolerated at the doses tested and shows preliminary evidence of clinical activity in disease types not typically treated with approved vinca alkaloids.
In 2010, the total cost of cancer care in the United States reached $125 billion. Globally, the economic toll from cancer is nearly 20 percent higher than the leading cause of death, heart disease. Cancer patients are also living longer today, which is further increasing the cost of their continued care.
Imagine creating an eye chart for someone who can't read or tell you what they see.
The National Institutes of Health is trying to cope with the effects of the government shutdown on patients and medical research.
The landmark breast cancer screening study of women 40-49, published online in Cancer, has proven that annual mammography screening of women in their 40s reduces the breast cancer death rate in these women by nearly 30 percent.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Pamela Gutbier Meliski, MD 75b Livingston St, Asheville, NC 28801-4353 Ph: (828) 258-8800 | Dr Pamela Gutbier Meliski, MD 75b Livingston St, Asheville, NC 28801-4353 Ph: (828) 258-8800 |
News Archive
AMRI announced today that on-going results from its Phase I clinical study on its novel tubulin inhibitor, ALB 109564(a), were published on the website of the American Society of Clinical Oncology (abstract.asco.org/alb). These results indicate that ALB 109564(a) is well tolerated at the doses tested and shows preliminary evidence of clinical activity in disease types not typically treated with approved vinca alkaloids.
In 2010, the total cost of cancer care in the United States reached $125 billion. Globally, the economic toll from cancer is nearly 20 percent higher than the leading cause of death, heart disease. Cancer patients are also living longer today, which is further increasing the cost of their continued care.
Imagine creating an eye chart for someone who can't read or tell you what they see.
The National Institutes of Health is trying to cope with the effects of the government shutdown on patients and medical research.
The landmark breast cancer screening study of women 40-49, published online in Cancer, has proven that annual mammography screening of women in their 40s reduces the breast cancer death rate in these women by nearly 30 percent.
› Verified 7 days ago
Peter G Mangone, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 60 Livingston St, Suite 100, Asheville, NC 28801 Phone: 828-258-8800 Fax: 828-281-7178 | |
Dr. Keith M Maxwell, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 21 Turtle Creek Dr, Asheville, NC 28803 Phone: 828-274-4555 Fax: 828-274-3615 | |
Dr. Wallace Taylor Harris, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 75b Livingston St, Asheville, NC 28801 Phone: 828-258-8800 | |
Michael J Goebel, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 75b Livingston St, Asheville, NC 28801 Phone: 828-258-8800 Fax: 828-281-7178 | |
Charles M. Lecroy, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 509 Biltmore Ave, Asheville, NC 28801 Phone: 828-213-1995 | |
Andrew V Prizigley, PA-C Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7 Vanderbilt Park Dr, Asheville, NC 28803 Phone: 828-255-7776 |